Spravato®RegistergeprüftModell benannter Zentren

Szpital Wojewódzki Im. Prymasa Kardynała Stefana Wyszyńskiego W Sieradzu

Warta, Polen

Behandlung & Zugang

Über diesen Anbieter

Details auf Englisch.

The Psychiatric Center in Warta is part of the Cardinal Stefan Wyszyński Provincial Hospital in Sieradz. Its Observation-Diagnostic Ward 3 specializes in treatment-resistant mental disorders and explicitly offers intranasal esketamine under NFZ drug program B.147, alongside intravenous racemic ketamine infusions, electroconvulsive therapy and lithium augmentation. The ward team includes psychiatrists, psychologists, a sexologist and a social worker, with EEG, ECG and imaging diagnostics available; per NFZ data there was no waiting queue for the program as of mid-2026.

Leistungen & Programme

Details auf Englisch.

  • Observation-diagnostic psychiatric wards for adults, including diagnosis and therapy of treatment-resistant depression and severe psychoses
  • Intranasal esketamine under NFZ drug program B.147
  • Intravenous racemic ketamine infusions
  • Electroconvulsive therapy (ECT)
  • Lithium augmentation of treatment
  • Mental health outpatient clinic and Mental Health Center in Warta
  • EEG, ECG and imaging diagnostics

Häufige Fragen

Details auf Englisch.

Where exactly is the esketamine program run — in Sieradz or in Warta?

At the Psychiatric Center in Warta (ul. Sieradzka 3, Warta), which is an organizational part of the Provincial Hospital in Sieradz. Observation-Diagnostic Ward 3 lists intranasal esketamine under program B.147 among its treatment options.

What do I need to qualify for program B.147 here?

You must be 18-75 with a current moderate-to-severe depressive episode that has not responded to at least two antidepressants used adequately. Qualification is done by the center's psychiatrists; bring your referral and prior treatment documentation. Treatment under the program is fully NFZ-funded for up to 34 weeks.

What if esketamine is not suitable for me?

This ward is unusual in offering several options for treatment-resistant depression at one site — IV racemic ketamine infusions, electroconvulsive therapy and lithium augmentation — so the team can propose an alternative pathway after assessment.

Alternativen im Blick? One of the NFZ program B.147 centers — see all program centers in Poland in the directory and the Poland access guide.

Verifizierung

Dieser Eintrag stammt direkt aus einem offiziellen Register oder einer Programmliste und wird in rollierendem Turnus erneut geprüft.

Einen Fehler entdeckt? Siehe unsere Methodik (auf Englisch) — dort steht, wie Einträge geprüft werden und wie Sie eine Korrektur melden.